Cytomegalovirus Infections

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

CMV-CMI in csCMVi After HSCT

Anti-viral T-cell Therapy by Gamma Capture

Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

R-MVST Cells for Treatment of Viral Infections

Cytomegalovirus Infection in Patients With HIV-1 Infection

Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection

Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

Breakthrough CMV Lung Transplant -Multicentre

Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients

Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone